期刊文献+

血液制品生产工艺验证实践的探讨

Discussion on the practices of process validation for Blood products
下载PDF
导出
摘要 工艺验证是药品生产验证的重中之重。本文根据生产工艺验证的实践经验,从工艺验证的介入时间、验证策略、验证风险管理和验证执行等方面总结了血液制品工艺验证的一些心得体会。 Process validation is the most important one of the validations done for pharmaceuticals manufacturing. Ac- cording to the production practice of process validation, this paper summarizes some feelings and experiences what we learn about intervention time, validation strategy, validation risk management and implementation of the practices in process validation of blood products.
出处 《中国当代医药》 2013年第8期161-163,共3页 China Modern Medicine
关键词 工艺验证 验证策略 风险管理 血液制品 Process validation Validation strategy Risk management Blood products
  • 相关文献

参考文献9

  • 1FDA,CDRH/CDER. Guideline on general principles of process valida- tion[S]. 1987.
  • 2FDA,CDER/CBER. Process validation:general principles and prac- tices[S]. 2011.
  • 3Paul L. Pluta,DavidW. Vincent,David E.Jones,et,al. Process perfor- mance-conformance lots[J]. Joumal of Validation Technology,2008, 14(4):59-71.
  • 4A. Hamid Mollah. Risk analysis and process validation[J]. BioProcess International, 2004,2 (9) : 28-36.
  • 5Harmonization of medical device regulation kuala lumpur. Quality Management Systems-Process Validation Guidance[S]. GHTF/SG3/ N99-10,2004.
  • 6David Vincent, Bill Honeck. Risk Management analysis techniques for validation programs[J]. Journal of Validation Technology,2004, l0 (3):235-251.
  • 7A. Hamid Mollah. Application of failure mode and effect analysis (FMEA)for process risk assessment[J]. BioProcess International,2005, 3(10):12-20.
  • 8余鼎,江砚芳,左冬,龙岭,刘海建.Wet Loop Calibration实现血浆蛋白分离自控系统的温度追溯[J].中国输血杂志,2010,23(2):128-130. 被引量:1
  • 9陈晓莉.药品生产工艺验证的研究[J].中国药事,2008,22(12):1122-1125. 被引量:16

二级参考文献10

  • 1Fed. Reg., 43, No. 190 [S] . 1978.
  • 2F'DA. Guideline on general principles of process validation [S] . 1987.
  • 3Frederick J, Carleton. validation of aseptic pharmaceutical processes 4[Z] . 1998.
  • 4Rifino C. B. Process validation of a new solid dosage from product, presented at Pharmaceutical Technology Conference, Validation Session [Z] . 1982.
  • 5FDA. Guide to inspection of bulk pharmaceutical chemicals [S]. 1991.
  • 6Handbook of pharmaceutical generic development[Z] . volume 20, part one, sterile injections, chapter 17.
  • 7Byers T. E. Design for quality. Presented at the Manufacturing controls seminar [Z] . October 11, 1974.
  • 8倪道明.血浆蛋白分离概论∥王憬惺.血液制品学.2版,北京:人民卫生出版社,1998:28-31.
  • 9Cohn E J, Strong LE, Huges WL, et al. Preparation and properties of serum and plasma proteins IV A system for the separation into fractions of the protein and lipeprotein components of biological tissues and fluids. Amer Chem Soc,1946,68(3) :459-475.
  • 10Kistler P, Nitschmann H. Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kisfler and Lergier. Vox Sang, 1962, 7 (4) :414-424.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部